Literature DB >> 21645026

Expression of interleukin-22 in Sjögren's syndrome: significant correlation with disease parameters.

T N Lavoie1, C M Stewart, K M Berg, Y Li, C Q Nguyen.   

Abstract

Sjögren's syndrome (SS) is an autoimmune disease targeting the exocrine glands resulting in xerostomia/keratoconjunctivitis sicca. Presently, we examined the levels and clinical correlations of IL-22 in SS. Patients with SS together with normal controls were randomly selected. IL-22 was detected at significantly higher levels in sera of patients with SS. The levels of IL-22 present in sera showed statistically significant direct correlations with hyposalivation, anti-SSB, anti-SSA/SSB combined, hypergammaglobulinemia and rheumatoid factor. IL-22 showed a direct correlation with major clinical parameters. The data suggest that IL-22 plays a critical role in the development of SS, and further study is needed to examine its function in human SS.
© 2011 The Authors. Scandinavian Journal of Immunology © 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21645026      PMCID: PMC3250060          DOI: 10.1111/j.1365-3083.2011.02583.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  33 in total

Review 1.  Current concepts on diagnosis, autoantibodies and therapy in Sjögren's syndrome.

Authors:  R Jonsson; H J Haga; T P Gordon
Journal:  Scand J Rheumatol       Date:  2000       Impact factor: 3.641

2.  Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes.

Authors:  S V Kotenko; L S Izotova; O V Mirochnitchenko; E Esterova; H Dickensheets; R P Donnelly; S Pestka
Journal:  J Biol Chem       Date:  2000-10-16       Impact factor: 5.157

Review 3.  Saliva and dental pellicle--a review.

Authors:  U Lendenmann; J Grogan; F G Oppenheim
Journal:  Adv Dent Res       Date:  2000-12

Review 4.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

5.  An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells.

Authors:  Gérard Eberl; Shana Marmon; Mary-Jean Sunshine; Paul D Rennert; Yongwon Choi; Dan R Littman
Journal:  Nat Immunol       Date:  2003-12-21       Impact factor: 25.606

6.  Abnormalities in peripheral B cell memory of patients with primary Sjögren's syndrome.

Authors:  Arne Hansen; Mirko Gosemann; Axel Pruss; Karin Reiter; Sarka Ruzickova; Peter E Lipsky; Thomas Dörner
Journal:  Arthritis Rheum       Date:  2004-06

7.  Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells.

Authors:  Marehalli L Nagalakshmi; Anne Rascle; Sandra Zurawski; Satish Menon; Rene de Waal Malefyt
Journal:  Int Immunopharmacol       Date:  2004-05       Impact factor: 4.932

8.  Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10.

Authors:  Diane Lejeune; Laure Dumoutier; Stefan Constantinescu; Wiebe Kruijer; Jan Jacob Schuringa; Jean-Christophe Renauld
Journal:  J Biol Chem       Date:  2002-06-26       Impact factor: 5.157

9.  IL-22 increases the innate immunity of tissues.

Authors:  Kerstin Wolk; Stefanie Kunz; Ellen Witte; Markus Friedrich; Khusru Asadullah; Robert Sabat
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

10.  Interleukin-22: a potential immunomodulatory molecule in the lung.

Authors:  Hayley A Whittington; Lynne Armstrong; Kay M Uppington; Ann B Millar
Journal:  Am J Respir Cell Mol Biol       Date:  2004-03-23       Impact factor: 6.914

View more
  19 in total

1.  IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs.

Authors:  Francesca Barone; Saba Nayar; Joana Campos; Thomas Cloake; David R Withers; Kai-Michael Toellner; Yang Zhang; Lynette Fouser; Benjamin Fisher; Simon Bowman; Javier Rangel-Moreno; Maria de la Luz Garcia-Hernandez; Troy D Randall; Davide Lucchesi; Michele Bombardieri; Costantino Pitzalis; Sanjiv A Luther; Christopher D Buckley
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-18       Impact factor: 11.205

2.  Interleukin-17 and -22 synergy linking inflammation and EMT-dependent fibrosis in Sjögren's syndrome.

Authors:  M Sisto; L Lorusso; R Tamma; G Ingravallo; D Ribatti; S Lisi
Journal:  Clin Exp Immunol       Date:  2019-06-05       Impact factor: 4.330

Review 3.  Update on Pathogenesis of Sjogren's Syndrome.

Authors:  Pulukool Sandhya; Biji Theyilamannil Kurien; Debashish Danda; Robert Hal Scofield
Journal:  Curr Rheumatol Rev       Date:  2017

Review 4.  Th17 cell cytokine secretion profile in host defense and autoimmunity.

Authors:  Kristen E Graeber; Nancy J Olsen
Journal:  Inflamm Res       Date:  2011-12-25       Impact factor: 4.575

Review 5.  Emerging role of interleukin-22 in autoimmune diseases.

Authors:  Hai-Feng Pan; Xiang-Pei Li; Song Guo Zheng; Dong-Qing Ye
Journal:  Cytokine Growth Factor Rev       Date:  2012-08-18       Impact factor: 7.638

Review 6.  The important role of T cells and receptor expression in Sjögren's syndrome.

Authors:  A Karabiyik; A B Peck; C Q Nguyen
Journal:  Scand J Immunol       Date:  2013-08       Impact factor: 3.487

7.  T Cell-Associated Cytokines in the Pathogenesis of Sjögren's Syndrome.

Authors:  Jun-O Jin; Qing Yu
Journal:  J Clin Cell Immunol       Date:  2013-02-26

Review 8.  Immunobiology of T Cells in Sjögren's Syndrome.

Authors:  Yuan Yao; Jin-Fen Ma; Christopher Chang; Ting Xu; Cai-Yue Gao; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Clin Rev Allergy Immunol       Date:  2021-02       Impact factor: 8.667

9.  AAV-IL-22 modifies liver chemokine activity and ameliorates portal inflammation in murine autoimmune cholangitis.

Authors:  Yu-Hsin Hsueh; Yun-Ning Chang; Chia-En Loh; M Eric Gershwin; Ya-Hui Chuang
Journal:  J Autoimmun       Date:  2015-11-01       Impact factor: 7.094

Review 10.  Targeting interleukin-22 in psoriasis.

Authors:  Ji-Qing Hao
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.